A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia
- 1 February 2002
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 112 (3) , 191-197
- https://doi.org/10.1016/s0002-9343(01)01089-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Treatment of fibromyalgia with antidepressantsJournal of General Internal Medicine, 2000
- Antidepressant Treatment of Fibromyalgia: A Meta-Analysis and ReviewPsychosomatics, 2000
- Citalopram in patients with fibromyalgia— a randomized, double‐blind, placebo‐controlled studyEuropean journal of pain, 2000
- Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparisonInternational Clinical Psychopharmacology, 1999
- A randomized, double‐blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgiaArthritis & Rheumatism, 1996
- A randomized controlled trial of citalopram in the treatment of fibromyalgiaPain, 1995
- The prevalence and characteristics of fibromyalgia in the general populationArthritis & Rheumatism, 1995
- Targeted pharmacotherapy in depression managementInternational Clinical Psychopharmacology, 1994
- A Double-blind Placebo Controlled Trial of Fluoxetine in FibromyalgiaScandinavian Journal of Rheumatology, 1994
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990